Molbio Diagnostics Ltd vs Vaidya Sane Ayurved Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Molbio Diagnostics Ltd is ₹ 1237 as of 23 Oct 15:30 . The P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2023 to 0 on March 2022 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Vaidya Sane Ayurved Laboratories Ltd changed from 51.1 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 6 years The Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Vaidya Sane Ayurved Laboratories Ltd changed from ₹ 247.07 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 6 years The Revenue of Molbio Diagnostics Ltd is ₹ 100.47 crore as of Jun '25 .The Revenue of Vaidya Sane Ayurved Laboratories Ltd is ₹ 0 crore as of Jun '25 . The EBITDA of Molbio Diagnostics Ltd is ₹ -15.35 crore as of Jun '25 .The EBITDA of Vaidya Sane Ayurved Laboratories Ltd is ₹ 0 crore as of Jun '25 . The Net Profit of Molbio Diagnostics Ltd is ₹ -23.94 crore as of Jun '25 .The Net Profit of Vaidya Sane Ayurved Laboratories Ltd is ₹ 0 crore as of Jun '25 . The Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vaidya Sane Ayurved Laboratories Ltd changed from 5.06 % on March 2023 to 0 % on March 2026 . This represents a CAGR of -100.00% over 4 years .

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

About Vaidya Sane Ayurved Laboratories Ltd

Vaidya Sane Ayurved Laboratories Limited was originally incorporated as a Private Limited Company pursuant to a Certificate of Incorporation issued by the Registrar of Companies, Pune dated April 6, 1999 with the name Vaidya Sane Ayurved Laboratories Private Limited'.
Subsequently, Company was converted into to a Public Limited Company and the name of Company was changed to Vaidya Sane Ayurved Laboratories Limited'.
A fresh Certificate of Incorporation upon conversion was issued on November 25, 2021 by the Registrar of Companies, Pune. The Company is a unique medical service institution to treat chronic ailments like cardiac disease, diabetes, hypertension and obesity with the distinctive outlook of amalgamating technology with traditional healing of Ayurveda.
Its approach to treatment using non-invasive, multidisciplinary and innovative therapies has helped the Company for treating the chronic ailments.

FAQs for the comparison of null and Vaidya Sane Ayurved Laboratories Ltd

Which company has a larger market capitalization, Molbio Diagnostics Ltd or Vaidya Sane Ayurved Laboratories Ltd?

Market cap of Molbio Diagnostics Ltd is 14,262 Cr while Market cap of Vaidya Sane Ayurved Laboratories Ltd is 153 Cr

What are the key factors driving the stock performance of Molbio Diagnostics Ltd and Vaidya Sane Ayurved Laboratories Ltd?

The stock performance of Molbio Diagnostics Ltd and Vaidya Sane Ayurved Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Molbio Diagnostics Ltd and Vaidya Sane Ayurved Laboratories Ltd?

As of October 25, 2026, the Molbio Diagnostics Ltd stock price is INR ₹1237.65. On the other hand, Vaidya Sane Ayurved Laboratories Ltd stock price is INR ₹146.45.

How do dividend payouts of Molbio Diagnostics Ltd and Vaidya Sane Ayurved Laboratories Ltd compare?

To compare the dividend payouts of Molbio Diagnostics Ltd and Vaidya Sane Ayurved Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.